PROCEPT BioRobotics (PRCT) Cash from Financing Activities (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Cash from Financing Activities data on file, last reported at $222000.0 in Q1 2026.

• Quarterly Cash from Financing Activities fell 82.9% year-over-year to $222000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.1 million (down 94.34% YoY) and the FY2025 annual result came in at $11.2 million, down 93.79% from the prior year.
• Cash from Financing Activities declined to $222000.0 in Q1 2026 per PRCT's latest filing, from $4.4 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $170.5 million in Q4 2024 and bottomed at -$1.3 million in Q4 2022.
• The 5-year median for Cash from Financing Activities is $2.4 million (2023), against an average of $21.3 million.
• The widest annual swing landed in 2022, when Cash from Financing Activities sank 304.66%; it then surged 20764.74% in 2023.
• Tracing PRCT's Cash from Financing Activities over 5 years: stood at -$1.3 million in 2022, then jumped by 317.45% to $2.9 million in 2023, then soared by 5850.03% to $170.5 million in 2024, then slumped by 97.4% to $4.4 million in 2025, then plunged by 95.0% to $222000.0 in 2026.
• Per Business Quant, the three latest PRCT Cash from Financing Activities figures stand at $222000.0 (Q1 2026), $4.4 million (Q4 2025), and $1.1 million (Q3 2025).

Peer Comparison